Software News and Research

RSS

Optibrium Enters Cheminformatics Collaboration with MSD

Optibrium today announced a collaboration with MSD tradename of Merck & Co., Inc, Kenilworth NJ USA.

From Optibrium Ltd. 10 Nov 2020

Open-source online platform offers better insight into biomedical images

Recent years have seen dramatic improvements in imaging technologies that result in higher resolutions and faster acquisition times.

10 Nov 2020

Researchers receive federal grant to develop tool that protects privacy in brain imaging analyses

Georgia State University faculty have received a five-year, $3 million federal grant to further develop a tool that will allow researchers around the world to participate in extensive brain imaging analysis without sharing protected patient data.

10 Nov 2020

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

Researchers from the University of Sydney’s School of Project Management within the Faculty of Engineering have developed a model which aims to predict the risk of people living with type 2 diabetes developing cardiovascular disease.

9 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

REGENHU launches its next generation 3D Bioprinter and software, the R-GEN series and SHAPER, in its mission to revolutionize medicine

REGENHU, a leading global bioprinting company, today announced the launch of the R-GEN platform and SHAPER, a new bioprinter and software designed to cover the entire biofabrication process.

From regenHU Ltd. 4 Nov 2020

Andrew Alliance Webinar: Improving reproducibility of large-scale experiments by using a pipette+ system

Karsten Krey, a researcher in the group of Prof Andreas Pichlmair, will present this study, supported by technical data.

3 Nov 2020

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

2 Nov 2020

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, announce the extension of a strategic collaboration to deliver industry-proven, innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development.

From Thermo Fisher Scientific Inc. 2 Nov 2020

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals belonging to the same phylum (Cnidaria) as sea anemones, jellyfish and corals.

30 Oct 2020

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

A new study published on the preprint server medRxiv in October 2020 reports a method to assess transmission potential for any event in the current pandemic, using what is known about the virus's spread, data on the mobility of individuals, and new ways of processing genomic sequencing data. The outcome is to determine whether cases are linked or not so as to take action to prevent further spread.

29 Oct 2020

New dataset can help analyze multiple storms, track health outcomes

Hurricanes and other tropical cyclones can severely impact human health in communities across the country, but data for these events is limited, especially in a format that is easy to link with human health outcomes.

29 Oct 2020

Autonomous robot uses UV light to kill COVID-19

Ultraviolet light is a form of radiation that can be used for sterilization and disinfection. With schools and offices beginning to meet in-person again despite little change in the rate of COVID-19 infections, easy, low-cost sterilization strategies are necessary to curb the spread of the pandemic.

28 Oct 2020

Uniqsis' FlowSyn Multi-X takes the drudgery out of reaction optimization

The FlowSyn Multi-X from Uniqsis takes the drudgery out of reaction optimization - effortlessly converting your batch chemistry methods to more efficient, higher yielding flow chemistry protocols.

From Uniqsis Ltd 28 Oct 2020

Policy debate should move beyond federal incentives and requirements to adopt health IT

Despite significant investment in health information technology such as computerized health records and clinical decision support, leveraging the technology to improve the quality of care will require significant and sustained effort by health systems, according to a new RAND Corporation study.

28 Oct 2020

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

28 Oct 2020

Dietary 1H-NMR “Fingerprints” Could Help Fight Against Chronic Disease

Metabolic urine profiling could provide an approach to understand what people have been eating, without them needing to tell you. Here, researchers from Imperial College London, Prof Gary Frost, Prof Elaine Holmes, and Dr. Isabel Garcia-Perez, explain why this could be invaluable to both nutritional research and individuals.

From Bruker BioSpin Group 27 Oct 2020

Software News and Research

Optibrium Enters Cheminformatics Collaboration with MSD

Open-source online platform offers better insight into biomedical images

Researchers receive federal grant to develop tool that protects privacy in brain imaging analyses

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

REGENHU launches its next generation 3D Bioprinter and software, the R-GEN series and SHAPER, in its mission to revolutionize medicine

Andrew Alliance Webinar: Improving reproducibility of large-scale experiments by using a pipette+ system

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

A2B-COVID: Rapid identification of SARS-CoV-2 transmission

New dataset can help analyze multiple storms, track health outcomes

Autonomous robot uses UV light to kill COVID-19

Uniqsis' FlowSyn Multi-X takes the drudgery out of reaction optimization

Policy debate should move beyond federal incentives and requirements to adopt health IT

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Dietary 1H-NMR “Fingerprints” Could Help Fight Against Chronic Disease

'White matter lesion' mapping tool can detect early signs of cognitive decline

For people with visual impairments, truly secret ballots are elusive

Graphene-enhanced PPE for COVID-19

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News